|
Volumn 6, Issue 6, 2008, Pages 1048-1049
|
A contribution to the debate on the laboratory criteria that define the antiphospholipid syndrome
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BETA2 GLYCOPROTEIN 1 ANTIBODY;
CARDIOLIPIN ANTIBODY;
IMMUNOGLOBULIN G;
IMMUNOGLOBULIN M;
LUPUS ANTICOAGULANT;
ANTIPHOSPHOLIPID SYNDROME;
DIAGNOSTIC ACCURACY;
DIAGNOSTIC VALUE;
ENZYME LINKED IMMUNOSORBENT ASSAY;
FALSE POSITIVE RESULT;
HUMAN;
LABORATORY DIAGNOSIS;
LETTER;
PRIORITY JOURNAL;
SENSITIVITY AND SPECIFICITY;
STANDARDIZATION;
ANTIBODIES, ANTIPHOSPHOLIPID;
ANTIPHOSPHOLIPID SYNDROME;
BETA 2-GLYCOPROTEIN I;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
HUMANS;
IMMUNOGLOBULIN G;
LUPUS COAGULATION INHIBITOR;
PHOSPHOLIPIDS;
REAGENT KITS, DIAGNOSTIC;
REPRODUCIBILITY OF RESULTS;
RISK FACTORS;
SENSITIVITY AND SPECIFICITY;
SEROLOGIC TESTS;
THROMBOEMBOLISM;
|
EID: 43749119820
PISSN: 15387933
EISSN: 15387836
Source Type: Journal
DOI: 10.1111/j.1538-7836.2008.02965.x Document Type: Letter |
Times cited : (33)
|
References (5)
|